Clover Biopharmaceuticals
Business Services · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
200 State St Ste 1105, Boston, Massachus...Phone Number
(866) 901-3295Website
www.cloverbiopharma.comRevenue
$172 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Clover Biopharmaceuticals
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing, and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. It is based in Chengdu, Sichuan in China.Explore more
Clover Biopharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Clover Biopharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Clover Biopharmaceuticals recently announced quarterly report
Clover Biopharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Clover Biopharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Clover Biopharmaceuticals
Click to see if Clover Biopharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Clover Biopharmaceuticals launches new products
Funding: Get notified immidiatlly once Clover Biopharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Check if Clover Biopharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Clover Biopharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Clover Biopharmaceuticals
Compare insights from companies similar to Clover Biopharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Clover Biopharmaceuticals
$172M
501-1,000
Private
$636.3M
2007
LC
LiongHo ChuaPresident, Greater (China)
$843.9M
1K - 5K
Private
-
2007
MP
Melissa Pickell-MattsonProgram Director, Human Resources & Chief of Staff
$28.2M
201-500
Private
$105M
2019
CG
Caroline GermaExecutive Vice President & Global Chief Medical Officer, Medicine Development
Company Profile Activity
Activity Insights
Clover Biopharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Clover Biopharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Clover Biopharmaceuticals.
Clover Biopharmaceuticals financials insights
Gather financial insights about Clover Biopharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$9.5M
2019
Series B
$43M
2020
Other Financing Round
$24M
Grant
$66M
2021
Series C
$230M
Stock Offering
$260.2M
2026
Private Equity
$3.6M
Clover Biopharmaceuticals Tech Stack
A closer look at the technologies used by Clover Biopharmaceuticals
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Project
Research & Development, Product Management, Intellectual Property, Medical Research, Pharmaceuticals, Clinical Operations
Left Company
Executive Move
Left Company
Executive Move
Clover Biopharmaceuticals News & Media
Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates -- SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage...Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced the appointment of Nicholas Jackson, Ph.D., as President of Global R&D and Alliances. Dr. Jackson will work closely with the Company's CEO, Joshua Liang, to accelerate the development of Clover's RSV+hMPV±PIV3 combination vaccine canClover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults
-- Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Increases in neutralizing antibodies of approximately 6-8 fold for RSV, 6-9 fold for hMPV and 4 fold for PIV3 (≥10 fold increases in PIV3 PreF-specific antibodies) were observed -- -- Interim analysis from RSV re-vaccination trial demonstrates ≥60% higher trend in RSV neutralizingClover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clover Biopharmaceuticals
Sign Up For FreeTo access detailed company insights
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing, and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. It is based in Chengdu, Sichuan in China.... Read More
